Barclays increases their price target for Vir Biotechnology (NASDAQ:VIR) to $28.00.

Vir Biotechnology (NASDAQ:VIR – Free Report) had its target price upped by Barclays from $27.00 to $28.00 in a report released on Friday morning, Benzinga reports. Barclays currently has an…

Read More: https://zolmax.com/investing/barclays-boosts-vir-biotechnology-nasdaqvir-price-target-to-28-00/10827311.html